Scrip Podcast-Ep4 March 2020:Coronavirus:Remdesivir and Pipeline Hopes–Long-Term Impact On Biopharma

Citeline Podcasts - A podcast by Citeline

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

A special edition focused on biopharma and the coronavirus pandemic. Taking a look at the coronavirus pipeline, including Gilead’s remdesivir ‘The People’s Hope’; has China beaten COVID-19? Plus the long-term impact on pharma R&D and commercial operations. Hosted by Andrew McConaghie, Brian Yang and Kevin Grogan from the Scrip Pharma Intelligence team in the UK and Beijing.

Visit the podcast's native language site